Articles / Biomechanical footwear shows promise for knee pain
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
According to a neat little randomised control trial published in JAMA, wearing individualised biomechanical footwear can significantly reduce knee pain in patients with osteoarthritis. The six-month study also showed that the footwear improved the function of the knee as judged by gait studies into velocity and step length.
The researchers say, because they were only looking at results over a 24 week period, they cannot predict the long-term clinical significance of their study findings, however for a condition that is becoming more and more common as our society gets older and fatter and where our therapeutic options are relatively limited, this study might prove useful.
JAMA. 2020;323(18):1802-1812. doi:10.1001/jama.2020.3565
Autism Spectrum Disorder in Children
LDL and Cardiovascular Disease
Donanemab – A GP Guide to Anti-Amyloid Therapies
Early Menopause
Within the next 12 months
Within the next 3 years
Within the next 5 years
Within the next 10 years
More than 10 years
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease